Physician profile
Anna Jackson
NPI 1093752198
$2,011.58
in general payments reported to CMS, 2019-2025
10 companies · $1,390 in 2025
The $1,390 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.28 · 2024: $607 · 2025: $1,390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,997.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $789.77 | 2024-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $245.86 | 2025 | Zepbound |
| Phathom Pharmaceuticals, INC. | $241.65 | 2025 | Voquezna |
| Glaxosmithkline, LLC. | $131.06 | 2019-2024 | Arexvy |
| Dexcom, INC. | $126.26 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Novo Nordisk INC | $118.53 | 2024 | |
| Axsome Therapeutics, INC. | $117.52 | 2025 | Auvelity |
| Exact Sciences Corporation | $116.07 | 2025 | The Cologuard Plus Collection Kit |
| Edwards Lifesciences Corporation | $109.09 | 2025 | Sapien 3 Ultra Resilia |
| Optinose US, INC. | $15.77 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.